Key result
Rosuvastatin-induced proteinuria resolves following dose reduction from to daily.
Why the study?
Does high-dose rosuvastatin cause proteinuria in patients with a solitary kidney?
Case Report (n=1)
Does high-dose rosuvastatin cause proteinuria in patients with a solitary kidney?
High-dose rosuvastatin may cause transient proteinuria in patients with a solitary kidney, which resolves with dose reduction.
Answers are grounded in this paper and cite their sources.
Warrants caution with high-dose rosuvastatin in solitary kidney patients; hypothesis-generating finding that extends statin safety signals and merits validation.
BACKGROUND: High-dose rosuvastatin (40 mg) has been associated with transient proteinuria, particularly in patients with severe chronic kidney disease. CASE SUMMARY: We report a 59-year-old woman with a solitary kidney who developed proteinuria while on rosuvastatin 40 mg daily. The reduction of the dose to 10 mg daily led to complete resolution of proteinuria. DISCUSSION: The Food and Drug Administration recommendations advise a dose reduction of rosuvastatin to 10 mg in patients with severe chronic kidney disease, but no guidance exists for individuals with a solitary kidney and preserved renal function. This case suggests that these patients may be at risk of rosuvastatin-associated proteinuria and could benefit from lower doses. TAKE-HOME MESSAGES: Clinicians should use caution when prescribing high-dose rosuvastatin in patients with a solitary kidney. Further study is warranted to clarify whether solitary kidney status independently increases the risk of proteinuria.
No takes yet. Share an insight, caveat, or question.
Stouffer et al. (2026) conducted a case report in Solitary kidney (n=1). Rosuvastatin was evaluated on Proteinuria. Rosuvastatin daily induced proteinuria in a 59-year-old woman with a solitary kidney, which completely resolved after reducing the dose to daily.
Synapse has enriched 10 related papers. Consider them for comparative context: